407 related articles for article (PubMed ID: 37769677)
1. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
[TBL] [Abstract][Full Text] [Related]
2. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
Perreault L; Pan Q; Mather KJ; Watson KE; Hamman RF; Kahn SE;
Lancet; 2012 Jun; 379(9833):2243-51. PubMed ID: 22683134
[TBL] [Abstract][Full Text] [Related]
3. 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial.
Al-Mrabeh A; Hollingsworth KG; Shaw JAM; McConnachie A; Sattar N; Lean MEJ; Taylor R
Lancet Diabetes Endocrinol; 2020 Dec; 8(12):939-948. PubMed ID: 33031736
[TBL] [Abstract][Full Text] [Related]
4. Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
Garrib A; Kivuyo S; Bates K; Ramaiya K; Wang D; Majaliwa E; Simbauranga R; Charles G; van Widenfelt E; Luo H; Alam U; Nyirenda MJ; Jaffar S; Mfinanga S;
Diabetologia; 2023 Oct; 66(10):1882-1896. PubMed ID: 37460828
[TBL] [Abstract][Full Text] [Related]
5. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
Feig DS; Donovan LE; Zinman B; Sanchez JJ; Asztalos E; Ryan EA; Fantus IG; Hutton E; Armson AB; Lipscombe LL; Simmons D; Barrett JFR; Karanicolas PJ; Tobin S; McIntyre HD; Tian SY; Tomlinson G; Murphy KE;
Lancet Diabetes Endocrinol; 2020 Oct; 8(10):834-844. PubMed ID: 32946820
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
[TBL] [Abstract][Full Text] [Related]
7. Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS).
Fritsche A; Wagner R; Heni M; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Dannecker C; Fritsche L; Valenta V; Schick R; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Dambeck U; Stumvoll M; Blüher M; Birkenfeld AL; Schwarz P; Hauner H; Clavel J; Seißler J; Lechner A; Müssig K; Weber K; Laxy M; Bornstein S; Schürmann A; Roden M; de Angelis MH; Stefan N; Häring HU
Diabetes; 2021 Dec; 70(12):2785-2795. PubMed ID: 34531293
[TBL] [Abstract][Full Text] [Related]
8. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
[TBL] [Abstract][Full Text] [Related]
9. Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
Heise T; Mari A; DeVries JH; Urva S; Li J; Pratt EJ; Coskun T; Thomas MK; Mather KJ; Haupt A; Milicevic Z
Lancet Diabetes Endocrinol; 2022 Jun; 10(6):418-429. PubMed ID: 35468322
[TBL] [Abstract][Full Text] [Related]
10. Age- and sex-specific effects of a long-term lifestyle intervention on body weight and cardiometabolic health markers in adults with prediabetes: results from the diabetes prevention study PREVIEW.
Zhu R; Craciun I; Bernhards-Werge J; Jalo E; Poppitt SD; Silvestre MP; Huttunen-Lenz M; McNarry MA; Stratton G; Handjiev S; Handjieva-Darlenska T; Navas-Carretero S; Sundvall J; Adam TC; Drummen M; Simpson EJ; Macdonald IA; Brand-Miller J; Muirhead R; Lam T; Vestentoft PS; Færch K; Martinez JA; Fogelholm M; Raben A
Diabetologia; 2022 Aug; 65(8):1262-1277. PubMed ID: 35610522
[TBL] [Abstract][Full Text] [Related]
11. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
Bohula EA; Scirica BM; Inzucchi SE; McGuire DK; Keech AC; Smith SR; Kanevsky E; Murphy SA; Leiter LA; Dwyer JP; Corbalan R; Hamm C; Kaplan L; Nicolau JC; Ophuis TO; Ray KK; Ruda M; Spinar J; Patel T; Miao W; Perdomo C; Francis B; Dhadda S; Bonaca MP; Ruff CT; Sabatine MS; Wiviott SD;
Lancet; 2018 Nov; 392(10161):2269-2279. PubMed ID: 30293771
[TBL] [Abstract][Full Text] [Related]
12. Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.
Zhu R; Jalo E; Silvestre MP; Poppitt SD; Handjieva-Darlenska T; Handjiev S; Huttunen-Lenz M; Mackintosh K; Stratton G; Navas-Carretero S; Pietiläinen KH; Simpson E; Macdonald IA; Muirhead R; Brand-Miller J; Fogelholm M; Færch K; Martinez JA; Westerterp-Plantenga MS; Adam TC; Raben A
Diabetes Care; 2022 Nov; 45(11):2698-2708. PubMed ID: 35696263
[TBL] [Abstract][Full Text] [Related]
13. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
[TBL] [Abstract][Full Text] [Related]
14. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium.
Koivula RW; Forgie IM; Kurbasic A; Viñuela A; Heggie A; Giordano GN; Hansen TH; Hudson M; Koopman ADM; Rutters F; Siloaho M; Allin KH; Brage S; Brorsson CA; Dawed AY; De Masi F; Groves CJ; Kokkola T; Mahajan A; Perry MH; Rauh SP; Ridderstråle M; Teare HJA; Thomas EL; Tura A; Vestergaard H; White T; Adamski J; Bell JD; Beulens JW; Brunak S; Dermitzakis ET; Froguel P; Frost G; Gupta R; Hansen T; Hattersley A; Jablonka B; Kaye J; Laakso M; McDonald TJ; Pedersen O; Schwenk JM; Pavo I; Mari A; McCarthy MI; Ruetten H; Walker M; Pearson E; Franks PW;
Diabetologia; 2019 Sep; 62(9):1601-1615. PubMed ID: 31203377
[TBL] [Abstract][Full Text] [Related]
15. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
Lean MEJ; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Welsh P; Kean S; Ford I; McConnachie A; Messow CM; Sattar N; Taylor R
Lancet Diabetes Endocrinol; 2019 May; 7(5):344-355. PubMed ID: 30852132
[TBL] [Abstract][Full Text] [Related]
16. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes.
Stefan N; Staiger H; Wagner R; Machann J; Schick F; Häring HU; Fritsche A
Diabetologia; 2015 Dec; 58(12):2877-84. PubMed ID: 26404062
[TBL] [Abstract][Full Text] [Related]
17. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.
RISE Consortium
Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506
[TBL] [Abstract][Full Text] [Related]
18. Effects of a Community-Based Healthy Lifestyle Intervention Program (Co-HELP) among Adults with Prediabetes in a Developing Country: A Quasi-Experimental Study.
Ibrahim N; Ming Moy F; Awalludin IA; Mohd Ali Z; Ismail IS
PLoS One; 2016; 11(12):e0167123. PubMed ID: 27935988
[TBL] [Abstract][Full Text] [Related]
19. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.
Khunti K; Griffin S; Brennan A; Dallosso H; Davies M; Eborall H; Edwardson C; Gray L; Hardeman W; Heathcote L; Henson J; Morton K; Pollard D; Sharp S; Sutton S; Troughton J; Yates T
Health Technol Assess; 2021 Dec; 25(77):1-190. PubMed ID: 34995176
[TBL] [Abstract][Full Text] [Related]
20. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Lean ME; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Stefanetti R; Trenell M; Welsh P; Kean S; Ford I; McConnachie A; Sattar N; Taylor R
Lancet; 2018 Feb; 391(10120):541-551. PubMed ID: 29221645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
